| Glenmark Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532296 |
NSE Symbol : GLENMARK |
P/E(TTM) : 43.50 |
|
ISIN Demat : INE935A01035 |
Div & Yield% : 0.22 |
EPS(TTM) : 51.73 |
|
Book Value(₹) : 855.71 |
Market Cap(₹Cr) : 63,509.02 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 8,440.10 | 9,226.41 | 7,891.12 | 8,220.66 | 8,141.58 |
| Other Income | 772.02 | 356.37 | 6,238.36 | 985.94 | 1,044.96 |
| Stock Adjustments | 105.42 | -44.48 | 103.07 | 31.37 | 16.13 |
| Total Income | 9,317.54 | 9,538.30 | 14,232.55 | 9,237.97 | 9,202.67 |
| EXPENDITURE : | |||||
| Raw Materials | 3,184.37 | 3,154.65 | 3,313.19 | 3,427.07 | 3,425.06 |
| Power and Fuel Cost | 112.65 | 114.62 | 104.92 | 95.09 | 91.34 |
| Other Manufacturing Expenses | 370.83 | 372.36 | 375.32 | 304.66 | 347.04 |
| Selling and Administration Expenses | 1,593.61 | 1,305.30 | 1,199.17 | 1,246.10 | 1,062.89 |
| Miscellaneous Expenses | 2,217.11 | 566.49 | 325.15 | 855.71 | 349.97 |
| Employee Benefit Expenses | 1,790.41 | 1,603.50 | 1,434.78 | 1,346.51 | 1,193.20 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 48.57 | 2,421.38 | 7,480.02 | 1,962.84 | 2,733.18 |
| Interest | 78.75 | 48.73 | 277.11 | 206.82 | 236.04 |
| Gross Profit | -30.18 | 2,372.65 | 7,202.91 | 1,756.02 | 2,497.14 |
| Depreciation | 235.89 | 218.63 | 202.16 | 184.15 | 159.70 |
| Profit Before Tax | -266.07 | 2,154.02 | 7,000.75 | 1,571.87 | 2,337.44 |
| Current Tax | -724.52 | 600.76 | 1,049.99 | 386.93 | 411.08 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 659.25 | -57.09 | 783.46 | -23.83 | -71.42 |
| Reported Net Profit | -200.80 | 1,610.35 | 5,167.29 | 1,208.77 | 1,997.79 |
| Extraordinary Items | -1,143.27 | -152.91 | 3,742.26 | -369.56 | 354.02 |
| Adjusted Net Profit | 942.47 | 1,763.26 | 1,425.03 | 1,578.33 | 1,643.77 |
| Adjustment below Net Profit | -16.96 | -6.47 | -4.76 | 0.63 | 1.61 |
| Profit/Loss Balance carried down | 22,581.15 | 21,088.13 | 16,002.82 | 14,863.96 | 12,921.86 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 266.25 | 110.87 | 77.22 | 70.54 | 57.30 |
| P & L Balance carried down | 22,097.15 | 22,581.15 | 21,088.13 | 16,002.82 | 14,863.96 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 500.00 | 250.00 | 250.00 | 250.00 | 250.00 |
| Dividend Per Share(Rs) | 5.00 | 2.50 | 2.50 | 2.50 | 2.50 |
| Earnings Per Share-Unit Curr | -7.12 | 57.07 | 183.11 | 42.84 | 70.80 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 855.79 | 868.35 | 814.01 | 633.57 | 593.21 |
| Book Value(Adj)-Unit Curr | 855.79 | 868.35 | 814.01 | 633.57 | 593.21 |
